Wednesday, January 20, 2021

Daily Trading Analysis 20.01.2021

Trading Analysis of EUR/USD
Yellen: As rates remain at historic lows, the smartest thing to do is to pass a massive bailout program:
Called on Congress to act to support the economy;
The former Fed chair emphasized that low rates allow action;
Plans to create a competitive economy to create jobs;
Promises to focus on the needs of American workers;
Will work overtime to create a second bailout package.

Our Analysis:

Provided that the currency pair is traded above 1.2115, follow the recommendations below:
  • Time frame: 30 min
  • Recommendation: long position
  • Entry point: 1.2144
  • Take Profit 1: 1.2180
  • Take Profit 2: 1.2200

Alternative scenario:

In case of breakdown of the level 1.2115, follow the recommendations below:
  • Time frame: 30 min
  • Recommendation: short position
  • Entry point: 1.2115
  • Take Profit 1: 1.2090
  • Take Profit 2: 1.2070

Trading Analysis of GOLD/USD

Gold prices are rising on the prospect of extended fiscal stimulus and continued accommodative monetary policy in the U.S., but are holding near the 1.5-month low reached earlier due to the rising dollar.

Our Analysis:

Provided that the price is above 1836.00, follow these recommendations:
  • Time frame: 30 min
  • Recommendation: long position
  • Entry point: 1845.00
  • Take Profit 1: 1857.00
  • Take Profit 2: 1865.00 

Alternative scenario:

In case of breakdown of the level 1836.00, follow the recommendations below:
  • Time frame: 30 min
  • Recommendation: short position
  • Entry point: 1836.00
  • Take Profit 1: 1829.00
  • Take Profit 2: 1823.00

Fundamental Trading
Analysis of Pfizer 
Investors have been injecting an incredible amount of money into promising biotechnology last year, and it started even before the coronavirus pandemic further accelerated the trend. This capital doesn't go straight into the big pharmaceutical companies, but it will eventually be reflected in Pfizer's bottom line.
Over the next five years, investors can expect to see many more new drug approvals coming out of Pfizer's portfolio than they are used to. That's why the recent frenzy over biotech startups makes Pfizer a good company to buy now and hold for the long term.

Our Analysis:

Provided that the price is below 38.10, follow these recommendations:
  • Time frame: D1
  • Recommendation: short position
  • Entry point: 36.50
  • Take Profit 1: 34.90
  • Take Profit 2: 34.00

Alternative scenario:

In case of breakout of the level 38.10, follow the recommendations below:
  • Time frame: D1
  • Recommendation: long position
  • Entry point: 38.10
  • Take Profit 1: 39.46
  • Take Profit 2: 40.50

Risk Warning: Forex and CFD trading carry a high degree of risk. As such they may not be suitable for all investors. Investors should ensure they fully understand the risks associated with CFD trading before deciding to trade. Investors may choose to seek independent advice and should not risk more than they are prepared to lose.

No comments:

Post a Comment

Private investors pour $50 billion into booming sector… investment opportunity

Unstoppable megatrend driven by hundreds of billions in government spending ...